Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance

BACKGROUND: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP‐1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcomes, mean there may be benefits to switchi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Akshay B., Ali, Amar, Gorgojo Martínez, Juan J., Hramiak, Irene, Kavia, Ketan, Madsbad, Sten, Potier, Louis, Prohaska, Ben D., Strong, Jodi L., Vilsbøll, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900946/
https://www.ncbi.nlm.nih.gov/pubmed/32975890
http://dx.doi.org/10.1111/ijcp.13731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900946/
https://www.ncbi.nlm.nih.gov/pubmed/32975890
http://dx.doi.org/10.1111/ijcp.13731

Ejemplares similares